Clario | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Clario is a prominent clinical trial management and endpoint technology company based in Philadelphia, Pennsylvania. With over 50 years of experience, it has supported more than 30,000 clinical trials in over 100 countries, contributing to a significant number of FDA and EMA drug approvals. Formed in 2021 through the merger of Bioclinica and a Nordic Capital portfolio company, Clario expanded its capabilities further with the acquisition of AI-powered software company ArtiQ in 2024.

The company delivers a broad range of endpoint data solutions integrating clinical trial modalities such as electronic clinical outcome assessments, cardiac safety monitoring, medical imaging, and precision motion analysis. Its technology platform incorporates over 30 AI solutions, enhancing efficiency and accuracy in clinical trial endpoint analysis. Clario serves pharmaceutical, biotechnology, and medical device companies, and is committed to advancing technology, driving operational improvements, and fostering diversity and inclusion in its workforce.